Works matching IS 20457634 AND DT 2023 AND VI 12 AND IP 20


Results: 21
    1
    2

    Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 20, p. 20353, doi. 10.1002/cam4.6621
    By:
    • Chiorean, E. Gabriela;
    • Picozzi, Vincent;
    • Li, Chung‐Pin;
    • Peeters, Marc;
    • Maurel, Joan;
    • Singh, Jaswinder;
    • Golan, Talia;
    • Blanc, Jean‐Frédéric;
    • Chapman, Sonya C.;
    • Hussain, Anwar M.;
    • Johnston, Erica L.;
    • Hochster, Howard S.
    Publication type:
    Article
    3
    4
    5

    Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 20, p. 20423, doi. 10.1002/cam4.6588
    By:
    • Belle, Fabiën N.;
    • Schindera, Christina;
    • Ansari, Marc;
    • Armstrong, Gregory T.;
    • Beck‐Popovic, Maja;
    • Howell, Rebecca;
    • Leisenring, Wendy M.;
    • Meacham, Lillian R.;
    • Rössler, Jochen;
    • Spycher, Ben D.;
    • Tonorezos, Emily;
    • von der Weid, Nicolas X.;
    • Yasui, Yutaka;
    • Oeffinger, Kevin C.;
    • Kuehni, Claudia E.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Issue Information.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 20, p. 20225, doi. 10.1002/cam4.4882
    Publication type:
    Article
    17
    18
    19
    20
    21